glp-1 news november 3 2025 Pipeline Update: August - Prime Therapeutics GLP-1 Trends

In 2021, the results of a meta-analysis that included 7 RCT studies showed that GLP-RA uses resulted in a decreased risk of respiratory disease [43]

Women continue to dominate usage, accounting for 77% of current users compared with 23% of men

Compounded Market Dynamics: According to Novo Nordisk executives quoted in CNBC coverage, the company believes the Wegovy pill pricing approaches what some patients pay for compounded versions

15 Suppl 1 (Suppl 1)

This innovative approach effectively bypasses the traditional barriers associated with oral peptide delivery, offering a clinically viable and patient-preferred alternative to injectable formulations

Additionally, compounded products are typically paid for out-of-pocket, which can be more financially prohibitive than branded therapies covered under commercial insurance plans